Lingeng Lu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Complementary and Manual Therapy top 0.5%
Papers in
-
- RNA modifications and cancer 19
- Epigenetics and DNA Methylation 12
- RNA Research and Splicing 11
-
- Cancer-related molecular mechanisms research 21
- MicroRNA in disease regulation 12
- Co-authors
- Herbert Yu (44 shared papers)Dionyssios Katsaros (24 shared papers)Harvey A. Risch (32 shared papers)Yingqun Huang (5 shared papers)Irene A. Rigault de la Longrais (7 shared papers)Lei Yan (2 shared papers)Amanda N. Kallen (2 shared papers)Michael E. Hume (6 shared papers)
- Journals
- Breast Cancer Research and Treatment (9 papers)Cancers (6 papers)Osteoarthritis and Cartilage (6 papers)Cancer Research (5 papers)Gynecologic Oncology (5 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Lingeng Lu
190 papers receiving 7.0k citations
Lingeng Lu's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 2.6k
- Complementary and Manual Therapy 229
- Molecular Biology 3.4k
- Oncology 965
- Obstetrics and Gynecology 206
Countries citing papers authored by Lingeng Lu
This map shows the geographic impact of Lingeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingeng Lu more than expected).
Fields of papers citing papers by Lingeng Lu
This network shows the impact of papers produced by Lingeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingeng Lu. The network helps show where Lingeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs Hit paper breakdown → | 2013 | 920 |
| 2 | 2007 | 255 | |
| 3 | 2008 | 226 | |
| 4 | 2015 | 200 | |
| 5 | 2014 | 185 | |
| 6 | 2012 | 156 | |
| 7 | 2010 | 123 | |
| 8 | 2016 | 121 | |
| 9 | 2021 | 114 | |
| 10 | 2018 | 100 | |
| 11 | 2011 | 95 | |
| 12 | 2013 | 94 | |
| 13 | 2004 | 89 | |
| 14 | 2013 | 88 | |
| 15 | 2009 | 88 | |
| 16 | 2011 | 84 | |
| 17 | 2015 | 82 | |
| 18 | 2017 | 81 | |
| 19 | 2013 | 78 | |
| 20 | 2015 | 78 |
About Lingeng Lu
Lingeng Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 197 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (19 papers), Epigenetics and DNA Methylation (12 papers), MicroRNA in disease regulation (12 papers), RNA Research and Splicing (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Endometrial and Cervical Cancer Treatments (9 papers). The work is most often cited by research in Cancer Research (2.6k citations), Complementary and Manual Therapy (229 citations), Molecular Biology (3.4k citations), Oncology (965 citations) and Obstetrics and Gynecology (206 citations). Lingeng Lu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Herbert Yu, Dionyssios Katsaros, Harvey A. Risch, Yingqun Huang, Irene A. Rigault de la Longrais, Lei Yan, Amanda N. Kallen, Michael E. Hume, Suresh D. Pillai and Mark Kidd. Their work appears in journals such as Breast Cancer Research and Treatment, Cancers, Osteoarthritis and Cartilage, Cancer Research and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.